Lidocaine

Last revised by Christopher Bong on 14 Aug 2023

Lidocaine, also known as lignocaine or its tradename Xylocaine, is a very commonly used amino amide local anesthetic in interventional radiology. It also has a wide range of medical applications. In practice, it is found in concentrations of 1%, 2% or as a combination with epinephrine.

  • local anesthetic

    • rapid onset of action with intermediate duration of action

    • infiltration, surface anesthesia or nerve blocks

    • transdermal patch (used in shingles)

  • antiarrhythmic drug

    • class 1b

    • IV route of administration for ventricular arrhythmias

  • prolong inactivation of fast voltage-gated sodium channels in neurons which are responsible for action potential propagation thus limiting or ceasing action potential generation

  • in the heart, it raises the depolarization threshold rendering the cardiomyocytes to less likely conduct or initiate early action potential generation in the treatment of arrhythmias

  • works within 4 minutes and lasts up to 3 hours

  • metabolized by the liver (CYP3A4 enzyme)

  • half life 90-120 minutes, can be prolonged in patients with hepatic impairment or heart failure

  • excreted in urine

First made and marketed under the name of Xylocaine by Nils Lofgren, a Swedish chemist in 1943. It has been available commercially since 1949.

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.